Insider Transactions in Q3 2024 at Teladoc Health, Inc. (TDOC)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 20
2024
|
Jason Eric Evans Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,065
+50.0%
|
-
|
|
Sep 12
2024
|
Thomas Mckinley Director |
BUY
Open market or private purchase
|
Direct |
4,000
+9.29%
|
$28,000
$7.69 P/Share
|
|
Sep 04
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
468
-1.37%
|
$3,276
$7.26 P/Share
|
|
Sep 04
2024
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
20,773
-50.0%
|
$145,411
$7.26 P/Share
|
|
Sep 03
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,114
-3.16%
|
$7,798
$7.16 P/Share
|
|
Sep 03
2024
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
1,617
-3.75%
|
$11,319
$7.16 P/Share
|
|
Sep 03
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
4,218
-5.11%
|
$29,526
$7.16 P/Share
|
|
Sep 03
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
1,777
-5.35%
|
$12,439
$7.16 P/Share
|
|
Sep 03
2024
|
James L. Cave INTERIM CAO |
SELL
Open market or private sale
|
Direct |
555
-3.86%
|
$3,885
$7.16 P/Share
|
|
Sep 03
2024
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
2,083
-4.09%
|
$14,581
$7.16 P/Share
|
|
Sep 03
2024
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
2,817
-5.74%
|
$19,719
$7.16 P/Share
|
|
Sep 03
2024
|
Nikolaos P. Nanis Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
1,033
-1.35%
|
$7,231
$7.16 P/Share
|
|
Sep 03
2024
|
Mala Murthy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,750
-9.26%
|
$61,250
$7.16 P/Share
|
|
Sep 03
2024
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
1,795
-3.84%
|
$12,565
$7.16 P/Share
|
|
Aug 30
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,117
+4.27%
|
-
|
|
Aug 30
2024
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
BUY
Exercise of conversion of derivative security
|
Direct |
5,504
+4.2%
|
-
|
|
Aug 30
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,313
+4.84%
|
-
|
|
Aug 30
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,920
+4.87%
|
-
|
|
Aug 30
2024
|
James L. Cave INTERIM CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,884
+4.29%
|
-
|
|
Aug 30
2024
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,768
+3.74%
|
-
|
|
Aug 30
2024
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
7,803
+5.23%
|
-
|
|
Aug 30
2024
|
Nikolaos P. Nanis Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,855
+0.94%
|
-
|
|
Aug 30
2024
|
Mala Murthy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,804
+4.21%
|
-
|
|
Aug 30
2024
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,023
+3.55%
|
-
|
|
Aug 15
2024
|
Mark Douglas Smith Director |
BUY
Open market or private purchase
|
Direct |
4,000
+32.38%
|
$28,000
$7.08 P/Share
|
|
Aug 12
2024
|
Nikolaos P. Nanis Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
206
-0.28%
|
$1,442
$7.13 P/Share
|
|
Aug 09
2024
|
Nikolaos P. Nanis Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
568
+0.76%
|
-
|
|
Aug 07
2024
|
Thomas Mckinley Director |
BUY
Open market or private purchase
|
Direct |
4,000
+10.24%
|
$28,000
$7.19 P/Share
|
|
Aug 07
2024
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-24.93%
|
$105,000
$7.6 P/Share
|
|
Aug 06
2024
|
Thomas Mckinley Director |
BUY
Open market or private purchase
|
Direct |
7,000
+18.38%
|
$49,000
$7.57 P/Share
|
|
Aug 05
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,537
-4.57%
|
$10,759
$7.33 P/Share
|
|
Aug 02
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
6,053
-7.54%
|
$48,424
$8.14 P/Share
|
|
Aug 02
2024
|
Laizer Kornwasser Advisor to the CEO |
SELL
Open market or private sale
|
Direct |
10,879
-9.82%
|
$87,032
$8.14 P/Share
|
|
Aug 02
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,857
-10.28%
|
$30,856
$8.14 P/Share
|
|
Aug 01
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,319
+12.36%
|
-
|
|
Aug 01
2024
|
Laizer Kornwasser Advisor to the CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,198
+15.42%
|
-
|
|
Aug 01
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,244
+21.45%
|
-
|
|
Jul 02
2024
|
Nikolaos P. Nanis Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
442
-0.6%
|
$3,978
$9.39 P/Share
|
|
Jul 01
2024
|
Nikolaos P. Nanis Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,233
+1.65%
|
-
|